Content (457)

  • US dollar dominance- Playing Jenga with the global monetary system

    White papers

    US dollar dominance: Playing Jenga with the global monetary system

    2025-09-24T15:46:00Z

    Assumptions that underpin the US dollar’s status as the world’s primary reserve currency are eroding more quickly than expected. What happens if the tower starts to collapse?

  • AI research trip reaffirms bullish outlook

    White papers

    AI research trip reaffirms bullish outlook

    2025-09-23T15:51:00Z

    Over the summer a group of our analysts and portfolio managers spent a week in San Francisco. The trip was an integral part of our ongoing research into artificial intelligence (AI) and related investment opportunities. Our scale as investors affords us exceptional corporate access and during our time in San Francisco we met senior leaders from around a dozen different technology companies, from heavyweights like NVIDIA and Broadcom to names operating throughout the data supply chain.

  • The rise of the Magnificent 7- Concentration risk versus earnings power

    White papers

    The rise of the Magnificent 7: Concentration risk versus earnings power

    2025-09-15T15:55:00Z

    Concerns about market concentration and the performance of the Magnificent 7 (Mag 7) stocks – Apple, Microsoft, Google, Amazon, Nvidia, Meta and Tesla – have become increasingly common in investor conversations. Many are questioning whether the current environment resembles a market bubble. To address this, we will take a closer look at the numbers and history to see how today’s market stacks up.

  • A wheel opportunity- Premium tyre makers use EVs to inflate margins

    White papers

    A wheel opportunity: Premium tyre makers use EVs to inflate margins

    2025-09-12T16:00:00Z

    The electric vehicle (EV) transition presents a significant opportunity for premium tyre manufacturers. EVs create unique demands on tyres that favour established industry leaders with advanced technological capabilities. At the same time, growing regulation and litigation on tyre particulate emissions, deforestation-risk rubber, and toxic tyre chemical compounds could reverse the market share growth of budget tyre entrants in Western markets. 

  • Clear skies ahead- Japan’s structural renaissance

    White papers

    Clear skies ahead: Japan’s structural renaissance

    2025-07-14T13:25:00Z

    Japan is undergoing a transformative moment that positions it as one of today’s most compelling investment opportunities. The temporary nature of trade tensions stands in contrast with a powerful combination of strong domestic-led growth and sweeping corporate governance reforms that are reshaping the economy. With valuations sitting well below both historical averages and global peers, investors now have a rare opportunity to invest in Japan’s structural transformation.

  • Electric Vehicle transition- poised to move through the gears

    White papers

    Electric Vehicle transition: poised to move through the gears

    2025-07-01T11:45:00Z

    Early market optimism on the electric vehicle (EV) transition has faded over the last two years as growth rates in Europe and the US have stalled. Today we can see a three-speed global EV market: China is surging ahead, Europe is showing renewed momentum, and the US is stuck in the slow lane. 

  • Resilient European High Yield market looks beyond tariff uncertainty

    White papers

    Resilient European High Yield market looks beyond tariff uncertainty

    2025-06-26T11:56:00Z

    We cannot ignore the dominant themes impacting markets across the world, but a resilient and supported European marketplace is well placed to prosper in these challenging times.

  • A bitter pill- what tariffs could mean for pharmaceutical firms and the wider healthcare industry

    White papers

    A bitter pill: what tariffs could mean for pharmaceutical firms and the wider healthcare industry

    2025-06-18T08:57:00Z

    The US government’s proposal to impose tariffs on pharmaceutical imports has ignited a complex debate, intertwining economic, healthcare, and geopolitical considerations. While the initiative aims to bolster domestic manufacturing and reduce reliance on foreign supply chains, it also raises concerns about drug affordability and availability, and has broader implications for the healthcare system.

  • Navigating the fog of tariffs in emerging market equities

    White papers

    Navigating the fog of tariffs in emerging market equities

    2025-06-16T09:00:00Z

    We don’t pretend to have all the answers on China and the US, and we reserve the right to change our minds – especially as Donald Trump changes his. Amid such market volatility we are not making bold macro calls, instead our focus is on thoughtful, quality-led stock selection.

  • Fixed Income

    White papers

    Midyear fixed-income outlook: Strategic scenarios for bond investors

    2025-06-12T14:23:00Z

    How will policy uncertainty and macro headwinds shape opportunities in fixed income?

  • Equity outlok

    White papers

    Midyear equity outlook: Staying selective amid volatility

    2025-06-10T14:07:00Z

    A year that began with a rosy outlook for equities was soon jolted by tariff announcements, sending markets reeling. Looking out for the remainder of 2025, we remain constructive in our outlook on equities. Tariff tumult and a challenging macroeconomic environment remain acute in many regions. 

  • Midyear macro outlook- A new dawn of uncertainty

    White papers

    Midyear macro outlook: A new dawn of uncertainty

    2025-06-03T13:12:00Z

    Geopolitical tensions, tariff uncertainty and global economic slowdown look set to define the second half of 2025. Our global CIO looks at why active management and research-led investing are the way to navigate this global complexity.